Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-093472
Filing Date
2025-07-02
Accepted
2025-07-02 21:03:24
Documents
2
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7161
2 EX-24 siga-ex24.htm EX-24 11197
  Complete submission text file 0000950170-25-093472.txt   19866
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SIGA TECHNOLOGIES, INC. 35 EAST 62ND STREET NEW YORK NY 10065
Business Address
Luckshire Daniel J (Reporting) CIK: 0001512677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38436 | Film No.: 251103550